Featured Bioprocessing Editorial
-
Closed-Loop Manufacturing Is The Cell Therapy Revolution We Need
6/18/2025
In cell therapy manufacturing, automated closed systems with integrated software controls offer numerous benefits over traditional open systems.
-
What Global Survey Says About Scant Patient Access To CAR-T Therapy
6/17/2025
The Worldwide Network for Blood and Marrow Transplantation initiated a survey to understand cost, infrastructure, and regulatory differences affecting access.
-
Scaling Up Manufacturing? Here's Why You Need A CMC Specialist
6/16/2025
CMC experts (whether in-house or outsourced) fill a vital role during the transition from small-scale production to larger operations for maintaining quality, consistency, and compliance.
-
Amgen Bets On Agility In The Age Of AI
6/13/2025
The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.
-
Peeling Back The Layers Of Radiolabeled Peptide Production
6/12/2025
From the moment radiolabeled drugs are made, it’s a race to get them to patients. Radioactive decay is just one of many complications. Here’s one company’s approach.
-
A Look At Elsa, The FDA's New AI Digital Assistant
6/12/2025
The U.S. FDA recently launched its very own generative AI tool called Elsa. It's designed to assist FDA employees across various functions, from scientific reviewers to investigators.
-
Navigating Data Management Requirements For Sterile Manufacturing
6/11/2025
Contamination control strategies are rooted in representative and trustworthy data, but companies still do a poor job at maximizing their use of data to optimize.
-
Multispecific Trial Supply Stability Hinges On CDMO Agility
6/10/2025
Naya's CEO describes the dynamics of producing a complex therapeutic for clinical trials on another continent, and how choice of CDMO plays heavily into that strategy.
-
The Promise And Challenges Of Cell-Free Protein Systems
6/10/2025
CFPS use cell lysates or purified enzymes to synthesize proteins. They have emerged as a promising alternative to production with living cells.
-
Bracing For The Impact Of The Federal Workforce Reduction
6/9/2025
The federal workforce reductions pose significant challenges for the life sciences industry, particularly for R&D, supply chain oversight, and industry workforce development.